Assessing trial eligibility and real-world response to vedolizumab and ustekinumab in patients with ulcerative colitis

Scandinavian Journal of Gastroenterology · Published 2026-07-06 · DOI 10.1080/00365521.2026.2697982

Authors (6)

Stephen Le Breton, Aditya Mithal, Tasnim Ahmed, Jini Huh, Konstantinos Papamichael, Adam S. Cheifetz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Breton, S., Mithal, A., Ahmed, T., et al. (2026). Assessing trial eligibility and real-world response to vedolizumab and ustekinumab in patients with ulcerative colitis. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00365521.2026.2697982

Related articles